The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)
Clinical trial NCT04073498 · COMPLETED
Trial details
- NCT number
- NCT04073498
- Sponsor
- ApcinteX Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-14
- Primary completion
- 2024-09-26
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.